Learn about the retirement of Candice Saunders, BSN, CEO of Wellstar Health System, and her decade-long impact on the organization through new care models, com ...

Monica Bertagnolli, MD, will step down as director of the National Institutes of Health, having served in the role since November 2023. She will leave the agency Jan. 17, three days before the ...

The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report. GoodRx analyzed the ...

Discover the top 10 long-term care hospitals with the lowest and highest preventable readmission rates, according to CMS data. Vibra Hospital of Denver ranks ...

A team from Charleston, S.C.-based MUSC Health's Heart and Vascular Center became the first in the country to implant the Topaz device, a new transcatheter tricuspid heart valve replacement system.

The Miriam Hospital in Providence, R.I., has named Seanna Zimmerman, DNP, RN, vice president and chief nursing officer. As CNO of the 247-bed hospital, she will oversee strategic initiatives to ...

For the rankings, U.S. News examined data from the U.S. Bureau of Labor Statistics to identify jobs with the greatest hiring demand. Jobs are then scored based on future prospects, wage potential, ...

BayCare appoints new C-suite leader and updates roles of two others, including promotion of Nikki Daily to chief team resources officer. Learn more in this hea ...

Irving, Texas-based Christus Health has broken ground on a $36 million cancer center in Longview, Texas. The new center will offer full-service oncology care and an outpatient clinic, as well as ...

There is no evidence that physician supervision of CRNAs improves the safety of patients or the quality of their care; however, there is compelling data showing that this practice increases costs for ...

Learn how City of Hope's staff and physicians bravely cared for cancer patients during the Eaton fire, just miles from their main campus.

The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...